---
figid: PMC6302261__ehy596f2
figtitle: Cardiac metabolic alterations in heart failure
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
- Candida dubliniensis
pmcid: PMC6302261
filename: ehy596f2.jpg
figlink: /pmc/articles/PMC6302261/figure/ehy596-F2/
number: F2
caption: Cardiac metabolic alterations in heart failure. In heart failure, increased
  uptake of free fatty acids and glucose into the cytosol is uncoupled from mitochondrial
  uptake and oxidation of free fatty acid and pyruvate, respectively. This provokes
  accumulation of metabolic intermediates in the cytosol which can trigger lipo- and
  glucotoxicity. Instead, utilization of ketone bodies is increased in heart failure.
  Impaired overall substrate oxidation reduces Krebs cycle (TCA) activity, oxidizing
  electron donors NADH and FADH2 for the electron transport chain (ETC). This reduces
  metabolic flux through creatine kinase (CK), thereby the phosphocreatine (PCr) to
  ATP ratio. β-Ox., β-oxidation; CPT-1/2, carnitine palmitoyltransferase type 1/2;
  FA-CoA, fatty acyl-coenzyme A; FACS, fatty acyl-coenzyme A synthetase; FAT/CD36,
  fatty acid translocase; GLUT 1/4, glucose transporters 1/4; G6P, glucose-6-phosphate;
  PDH, pyruvate dehydrogenase complex; PPP, pentose phosphate pathway; Polyol P.,
  Polyol pathway; TAG, triacylglycerol; UDPGlcNac, UDP-glycnacylation. Red arrows
  (↓↑) indicate the changes in heart failure.
papertitle: 'Heart failure and diabetes: metabolic alterations and therapeutic interventions:
  a state-of-the-art review from the Translational Research Committee of the Heart
  Failure Association–European Society of Cardiology.'
reftext: Christoph Maack, et al. Eur Heart J. 2018 Dec 21;39(48):4243-4254.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9607376
figid_alias: PMC6302261__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
redirect_from: /figures/PMC6302261__F2
ndex: c7329151-dedd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6302261__ehy596f2.html
  '@type': Dataset
  description: Cardiac metabolic alterations in heart failure. In heart failure, increased
    uptake of free fatty acids and glucose into the cytosol is uncoupled from mitochondrial
    uptake and oxidation of free fatty acid and pyruvate, respectively. This provokes
    accumulation of metabolic intermediates in the cytosol which can trigger lipo-
    and glucotoxicity. Instead, utilization of ketone bodies is increased in heart
    failure. Impaired overall substrate oxidation reduces Krebs cycle (TCA) activity,
    oxidizing electron donors NADH and FADH2 for the electron transport chain (ETC).
    This reduces metabolic flux through creatine kinase (CK), thereby the phosphocreatine
    (PCr) to ATP ratio. β-Ox., β-oxidation; CPT-1/2, carnitine palmitoyltransferase
    type 1/2; FA-CoA, fatty acyl-coenzyme A; FACS, fatty acyl-coenzyme A synthetase;
    FAT/CD36, fatty acid translocase; GLUT 1/4, glucose transporters 1/4; G6P, glucose-6-phosphate;
    PDH, pyruvate dehydrogenase complex; PPP, pentose phosphate pathway; Polyol P.,
    Polyol pathway; TAG, triacylglycerol; UDPGlcNac, UDP-glycnacylation. Red arrows
    (↓↑) indicate the changes in heart failure.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cd36
  - Cpe
  - Scarb1
  - Slc1a3
  - Slc2a1
  - Slc2a4
  - Acsl1
  - Tag
  - Gnat2
  - Fat1
  - RGD1565355
  - G4
  - Tmprss5
  - CD36
  - FAT1
  - SLC2A1
  - SLC2A4
  - TMED7
  - LINC01194
  - CHPT1
  - DHDDS
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - HMGA2
  - ATP8A2
  - APRT
  - MFAP1
---
